Skip to main content

Tom Schrader

Analyst

U.S. Bank

Equibles does not estimate personal net worth.

About Tom Schrader

Tom Schrader is recorded as Analyst at U.S. Bank. Tom Schrader has spoken on 1 earnings call and 1 other investor event across 2 companies, most recently for Harrow, Inc. on November 10, 2026. Those appearances were for Harrow, Inc. (HROW) and NRX Pharmaceuticals, Inc. (NRXP). The companies whose calls Tom Schrader spoke on are classified in the Healthcare sector.

Tom Schrader on recent calls

“Do you have a clear sense of what people testing the water want to see? Is it that you help them with reimbursement? Is it that your supply chain is easy? Do you know what they're looking for?”
Analyst — U.S. Bank, Third Quarter 2026 Earnings Conference Call and Webcast ·
“I'm wondering if in your interactions with the FDA, you got any read on their view of the preservative? And also, similarly, you talked a little bit about copying your vial as a risk, but don't you have IP around the preservative-free form of ketamine?”
Analyst — U.S. Bank, NRx Pharmaceuticals Conference Call to Discuss Regulatory Milestone for Preservative-Free Ketamine ·

Affiliation history

  • U.S. Bank

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity